Europe — EMA
Octanine F (Human Coagulation Factor Ix)
Human Coagulation Factor IX, the active ingredient in Octanine F, is a blood coagulation factor presented as an intravenous solution for intravenous use.
Request sourcing
What is Human Coagulation Factor Ix?
Human Coagulation Factor IX, the active ingredient in Octanine F, is a blood coagulation factor presented as an intravenous solution for intravenous use. It replaces deficient factor IX in patients with hemophilia B, helping to control bleeding episodes. GNH USA supplies Octanine F as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.
GNH USA supplies Octanine F as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.
What is Human Coagulation Factor Ix used for?
Octanine F is a recombinant factor IX product that operates
- Hemophilia B (Factor IX deficiency): Provides replacement factor IX to prevent or control bleeding. - Peri‑operative management in hemophilia B patients: Maintains adequate factor IX levels during surgery. - Trauma‑related bleeding in patients with known factor IX deficiency: Supplies needed factor IX to achieve hemostasis. - Acute bleeding episodes in hemophilia B: Restores factor IX activity to stop bleeding. - Prophylactic therapy for severe hemophilia B: Regular infusions to reduce frequency of spontaneous bleeds.
What are the side effects of Human Coagulation Factor Ix?
Octanine F may cause adverse reactions ranging from mild to severe. Monitoring during and after infusion is standard practice.
Common Side Effects: - Mild fever - Headache - Nausea - Injection site erythema - Transient elevation of liver enzymes - Fatigue
Serious or Rare Side Effects: - Anaphylactic reaction - Development of inhibitors (neutralizing antibodies) - Thromboembolic events - Severe hypersensitivity - Hemolysis - Renal impairment
What precautions apply to Human Coagulation Factor Ix?
When using Octanine F, clinicians should observe specific safety measures and patient‑specific considerations.
- Pre‑infusion screening: Assess for existing inhibitors or hypersensitivity. - Monitoring: Observe for signs of allergic reaction during and after infusion. - Dose adjustment: Tailor dosing based on individual pharmacokinetic response and factor IX activity levels. - Concomitant therapy: Use caution with other pro‑coagulant agents. - Pregnancy and lactation: Evaluate risk‑benefit ratio; limited data available. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.
What does Human Coagulation Factor Ix interact with?
Octanine F can interact with other agents that affect hemostasis, requiring careful clinical oversight.
Major Interactions (Avoid): - Concurrent use of activated ... ... … … ... … … … … … … … … … … … … … …
Moderate g t t """""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""."}



